Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 4;23(4):249-53.
doi: 10.1128/CVI.00053-16. Print 2016 Apr.

Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution

Thomas S Alexander  1
Affiliations
Review

Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution

Thomas S Alexander. Clin Vaccine Immunol. .

Abstract

A concern during the early AIDS epidemic was the lack of a test to identify individuals who carried the virus. The first HIV antibody test, developed in 1985, was designed to screen blood products, not to diagnose AIDS. The first-generation assays detected IgG antibody and became positive 6 to 12 weeks postinfection. False-positive results occurred; thus, a two-test algorithm was developed using a Western blot or immunofluorescence test as a confirmatory procedure. The second-generation HIV test added recombinant antigens, and the third-generation HIV tests included IgM detection, reducing the test-negative window to approximately 3 weeks postinfection. Fourth- and fifth-generation HIV assays added p24 antigen detection to the screening assay, reducing the test-negative window to 11 to 14 days. A new algorithm addressed the fourth-generation assay's ability to detect both antibody and antigen and yet not differentiate between them. The fifth-generation HIV assay provides separate antigen and antibody results and will require yet another algorithm. HIV infection may now be detected approximately 2 weeks postexposure, with a reduced number of false-positive results.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Centers for Disease Control/Food and Drug Administration algorithm for second-generation HIV tests (20). †, an immunofluorescence assay (IFA) for HIV-1 antibodies has recently been licensed by the Food and Drug Administration and can be used instead of the Western blot assay. Positive and negative IFA results should be interpreted in the same manner as similar results from Western blot tests. An indeterminate IFA result should first be tested by HIV-1 Western blot assay and then as indicated by the Western blot test results. §, perform HIV-2 EIA only if there is an identified risk factor for HIV-2 infection.
FIG 2
FIG 2
CDC algorithm for use with a fourth-generation HIV antibody/antigen screening test (21).
FIG 3
FIG 3
Schematic representation of the 30-year evolution of HIV diagnostic assays.
See this image and copyright information in PMC

References

    1. Pear R. 1985. AIDS blood test to be available in 2 to 6 weeks. http://www.nytimes.com/1985/03/03/us/aids-blood-test-to-be-available-in-... Accessed 26 January 2016.
    1. Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. 2014. Revised surveillance case definition for HIV infection—United States, 2014. MMWR Morb Recommend Rep 63(RR-03):1–10. - PubMed
    1. Gallo RC, Sarin PS, Gelmann EP, Robert-Guroff M, Richardson E, Kalyanaraman VS, Mann D, Sidhu GD, Stahl RE, Zolla-Pazner S, Leibowitch J, Popovic M. 1983. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220:865–867. doi:10.1126/science.6601823. - DOI - PubMed
    1. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnie L. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871. doi:10.1126/science.6189183. - DOI - PubMed
    1. Chappel RJ, Wilson KM, Dax EM. 2009. Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing. Future Microbiol 4:963–982. doi:10.2217/fmb.09.77. - DOI - PubMed